Stereotactic fractionated radiotherapy of the resection cavity as adjuvant treatment after resection of brain metastases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009357

Enrollment

Registered

2015-10-22

Start date

2013-11-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: For patients with 1-3- brain metastases who received an adjuvant stereotactic fractionated radiotherapy, the local and distant tumor control and the survival will be investigated retrospectiv

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with 1-3 brain metastases of a solid tumor where the indication for a whole brain irradiation existed, treatment by fractionated stereotactic irradiation after successful resection of the brain metastases

Exclusion criteria

Exclusion criteria: Germ cell tumors, lymphomas

Design outcomes

Primary

Measure	Time frame
Local tumor control	—

Secondary

Measure	Time frame
distant tumor control. Survival of patients with 1-3 brain metastases.	—

Countries

Germany

Contacts

Public ContactAngelika Bilger

Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde

angelika.bilger@uniklinik-freiburg.de+49 761 270 94120

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026